<DOC>
	<DOCNO>NCT01042457</DOCNO>
	<brief_summary>To evaluate therapeutic response MMF treatment patient International Society Nephrology/Renal Pathology Society ( ISN/RPS ) class III IV lupus nephritis . Mycophenolic acid level 1-hour post dose monitor monthly 6 month .</brief_summary>
	<brief_title>Concentration-controlled Therapy Mycophenolate Mofetil ( MMF ) Proliferative Lupus Nephritis</brief_title>
	<detailed_description />
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Age 1660 year . Ability willingness provide write informed consent ( obtain consent parent guardian applicable ) comply schedule protocol requirement Diagnosis SLE accord ACR criterion . At least 4 criterion must present diagnosis SLE . The 4 criterion present time screen Active lupus nephritis define follow : Biopsy proven ( within 16 week prior screen ) ISN Class III IV ( A A/C ) include III ( C ) IV ( C ) VI ( &gt; 90 % chronic irreversible scar ) Relates SLE Severe renal impairment define calculated creatinine clearance MDRDGFR &lt; 30 ml/min ( except creatinine clearance MDRDGFR &gt; 50 ml/min 12 week prior screen ) History serious disease complication organ system appropriate treatment immunosuppressive drug group . Related Treatment Previous Mycophenolate group 3 month prior screen . Treatment 2 g Cyclophosphamide last 6 month period prior screen . Receipt 3 g IV pulse methylprednisolone within last 3 month prior screen . Receipt prednisolone dose &gt; 30 mg/day longer 30 day within last 3 month prior screen . Related General Health Pregnancy breast feeding mother . Evidence significant uncontrolled concomitant disease organ system related SLE . History cancer , include solid tumor , hematological malignancy carcinoma . History serious recurrent chronic infection . Evidence current abuse drug alcohol . Related Laboratory Findings Neutrophile &lt; 1,500/mm3 , Hb &lt; 7g/L , Platelet &lt; 50,000/mm3 ( except active SLE ) Positive HBsAg antiHCV antiHIV .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>trough level</keyword>
	<keyword>therapeutic drug monitoring</keyword>
	<keyword>Mycophenolate mofetil</keyword>
	<keyword>Mycophenolic acid</keyword>
	<keyword>lupus nephritis</keyword>
</DOC>